Mark Sueyoshi

Mark Sueyoshi practices at University of Vermont Medical Center in Burlington, Vermont, part of University of Vermont Health Network.

Mark Sueyoshi's NPI, 1164911038, was assigned on May 7, 2018. Mark Sueyoshi graduated from University of California, Geffen School of Medicine in 2018. Mark Sueyoshi holds Vermont license 042-0017126.

Mark Sueyoshi's primary practice is University of Vermont Medical Center, at 111 Colchester Ave, Burlington, VT 05401 in Chittenden County. The practice phone is (802) 847-0000.

Mark Sueyoshi's primary practice is University of Vermont Medical Center in Burlington, Vermont, part of University of Vermont Health Network. Mark Sueyoshi is also affiliated with Central Vermont Medical Center. The medical group on file is University of Vermont Medical Center. Dmand AI also links Mark Sueyoshi to 1 more hospital, 1 dialysis center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mark Sueyoshi practices, 4 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Mark Sueyoshi's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Mark Sueyoshi is licensed in Vermont.

CMS data shows 1,918 Medicare services from Mark Sueyoshi across 15 procedure codes in 2024, for 209 Medicare patients. Medicare paid $128,574 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 209 Medicare patients who saw Mark Sueyoshi in 2024. The largest group is 65 to 74, with 106 patients. 69% of them have cancer, and 64% have high blood pressure. 17% are also on Medicaid. Their average risk score is 1.41, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Mark Sueyoshi's median patient age at 71, with 63% women.

In 2024, Mark Sueyoshi wrote 118 Medicare Part D claims for 52 patients. 96% of them were for generic drugs. CMS names the drug for 47 of them, across 3 drugs with 11 or more claims each, at $405 in total drug cost. In 2023, CMS named 25 claims across 2 drugs.

Mark Sueyoshi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Mark Sueyoshi as offering telehealth.

Dmand AI links 2 papers to Mark Sueyoshi in 2018. 2018 was the busiest year, with 2. Mark Sueyoshi's most frequent co-author is Elaine A. Hart, MD.

Mark Sueyoshi graduated from University of California, Geffen School of Medicine in 2018.